Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
— Low rates of toxicity and salvage cystectomy, with 2-year survival similar to surgery
Latest in Oncology/Hematology
First once-weekly subcutaneous prophylactic option for hemophilia B
Debate highlights pros and cons of the new recommendation
Likelihood of severe maternal morbidity more than 20 times higher versus the general population
Health news and commentary gathered by 51˶ staff
Likelihood of severe maternal morbidity more than 20 times higher versus the general population
Health news and commentary gathered by 51˶ staff
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease
Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone
News, features, and commentary about cancer-related issues
10% of patients in trials leading to eli-cel's approval developed MDS or AML
Bladder, brain, and cervical cancer risks were higher in people with MS
Differences in absolute, relative risk highlight complexities of analyzing rare events
Health news and commentary gathered by 51˶ staff
Two-year survival in second line for patients with BRAF/NRAS wild-type tumors
Study raises questions about how to assess patient risk, experts say
Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers
High overall response rate, even though many were ineligible for trial leading to drug's approval
Substantial drops in cancer-specific mortality affirmed in Chinese trial
News, features, and commentary about cancer-related issues
Rates rose after USPSTF recommendation, but increase was uneven
